In a new job - October 15, 2019
Athera’s CEO steps down after 13 years
The Athera Board of Directors has announced that James Hall is the new Chief Executive Officer in the company. Carina Schmidt steps down after nearly 13 years as CEO but will stay on as advisor and resource to the management and board in the work to reach planned milestones. ”During my years as CEO, Athera […]
Financing - May 21, 2019
Athera raises 55 million SEK
The biotech company has announced the closing of new share issue, raising in total 55 million SEK from current major shareholders including Industrifonden and Östersjöstiftelsen, together with new shareholders from the Sciety network of investors. The new capital will be used for a clinical Phase 2 study and Athera aims for partnering with a larger […]
Pharma Business - December 7, 2015
Karolinska Development sells Athera
Karolinska Development divests its entire shareholding in the drug development company Athera Biotechnologies to a consortium led by The Foundation for Baltic and East European Studies (Östersjöstiftelsen) and Industrifonden. Jim Van heusden, CEO of Karolinska Development, says: “I am very pleased to announce that we have concluded the divestment of Athera Biotechnologies to an investment […]
